Follow-up data were obtained from 85 patients (66.4%).In seven of the patients who died, four cases were related to erythroderma, three died of malignancies.

• 随访的85例患者中，4例死于皮质类固醇和免疫抑制剂应用导致的并发症，3例死于恶性肿瘤。